Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4
Zanconato, Francesca, Battilana, Giusy, Forcato, Mattia, Filippi, Letizia, Azzolin, Luca, Manfrin, Andrea, Quaranta, Erika, Di Biagio, Daniele, Sigismondo, Gianluca, Guzzardo, Vincenza, Lejeune, Pascale, Haendler, Bernard, Krijgsveld, Jeroen, Fassan, Matteo, Bicciato, Silvio, Cordenonsi, Michelangelo, Piccolo, Stefano
Published in Nature medicine (01.10.2018)
Published in Nature medicine (01.10.2018)
Get full text
Journal Article
SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies
DECKERT, Jutta, WETZEL, Marie-Cécile, DUMONTET, Charles, PLESA, Adriana, CHIRON, Marielle, LEJEUNE, Pascale, CHITTENDEN, Thomas, PARK, Peter U, BLANC, Véronique, BARTLE, Laura M, SKALETSKAYA, Anna, GOLDMACHER, Victor S, VALLEE, François, QING, Zhou-Liu, FERRARI, Paul, POUZIEUX, Stéphanie, LAHOUTE, Charlotte
Published in Clinical cancer research (01.09.2014)
Published in Clinical cancer research (01.09.2014)
Get full text
Journal Article
Preclinical Antitumor Activity of Cabazitaxel, a Semisynthetic Taxane Active in Taxane-Resistant Tumors
VRIGNAUD, Patricia, SEMIOND, Dorothée, LEJEUNE, Pascale, BOUCHARD, Hervé, CALVET, Loreley, COMBEAU, Cecile, RIOU, Jean-François, COMMERCON, Alain, LAVELLE, François, BISSERY, Marie-Christine
Published in Clinical cancer research (01.06.2013)
Published in Clinical cancer research (01.06.2013)
Get full text
Journal Article
Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201)
Borgmann, Hendrik, Lallous, Nada, Ozistanbullu, Deniz, Beraldi, Eliana, Paul, Naman, Dalal, Kush, Fazli, Ladan, Haferkamp, Axel, Lejeune, Pascale, Cherkasov, Artem, Gleave, Martin E.
Published in European urology (01.01.2018)
Published in European urology (01.01.2018)
Get full text
Journal Article
Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma
Bernasconi, Elena, Gaudio, Eugenio, Lejeune, Pascale, Tarantelli, Chiara, Cascione, Luciano, Kwee, Ivo, Spriano, Filippo, Rinaldi, Andrea, Mensah, Afua A., Chung, Elaine, Stathis, Anastasios, Siegel, Stephan, Schmees, Norbert, Ocker, Matthias, Zucca, Emanuele, Haendler, Bernard, Bertoni, Francesco
Published in British journal of haematology (01.09.2017)
Published in British journal of haematology (01.09.2017)
Get full text
Journal Article
Dispersion of Heat Flux Sensors Manufactured in Silicon Technology
Ziouche, Katir, Lejeune, Pascale, Bougrioua, Zahia, Leclercq, Didier
Published in Sensors (Basel, Switzerland) (09.06.2016)
Published in Sensors (Basel, Switzerland) (09.06.2016)
Get full text
Journal Article
The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies
Christian, Sven, Merz, Claudia, Evans, Laura, Gradl, Stefan, Seidel, Henrik, Friberg, Anders, Eheim, Ashley, Lejeune, Pascale, Brzezinka, Krzysztof, Zimmermann, Katja, Ferrara, Steven, Meyer, Hanna, Lesche, Ralf, Stoeckigt, Detlef, Bauser, Marcus, Haegebarth, Andrea, Sykes, David B, Scadden, David T, Losman, Julie-Aurore, Janzer, Andreas
Published in Leukemia (01.10.2019)
Published in Leukemia (01.10.2019)
Get full text
Journal Article
Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy
Lejeune, Pascale, Cruciani, Véronique, Berg-Larsen, Axel, Schlicker, Andreas, Mobergslien, Anne, Bartnitzky, Lisa, Berndt, Sandra, Zitzmann-Kolbe, Sabine, Kamfenkel, Claudia, Stargard, Stefan, Hammer, Stefanie, Jørgensen, Jennifer S, Jackerott, Malene, Nielsen, Carsten H, Schatz, Christoph A, Hennekes, Hartwig, Karlsson, Jenny, Cuthbertson, Alan S, Mumberg, Dominik, Hagemann, Urs B
Published in Journal for immunotherapy of cancer (01.10.2021)
Published in Journal for immunotherapy of cancer (01.10.2021)
Get full text
Journal Article
Early quantitative evaluation of a tumor vasculature disruptive agent AVE8062 using dynamic contrast-enhanced ultrasonography
Lavisse, Sonia, Lejeune, Pascale, Rouffiac, Valérie, Elie, Nicolas, Bribes, Estelle, Demers, Brigitte, Vrignaud, Patricia, Bissery, Marie-Christine, Brulé, Aude, Koscielny, Serge, Péronneau, Pierre, Lassau, Nathalie
Published in Investigative radiology (01.02.2008)
Published in Investigative radiology (01.02.2008)
Get more information
Journal Article
BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients
Sugawara, Tatsuo, Lejeune, Pascale, Köhr, Silke, Neuhaus, Roland, Faus, Hortensia, Gelato, Kathy A, Busemann, Matthias, Cleve, Arwed, Lücking, Ulrich, von Nussbaum, Franz, Brands, Michael, Mumberg, Dominik, Jung, Klaus, Stephan, Carsten, Haendler, Bernard
Published in Oncotarget (02.02.2016)
Published in Oncotarget (02.02.2016)
Get full text
Journal Article
Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models
Sugawara, Tatsuo, Baumgart, Simon J., Nevedomskaya, Ekaterina, Reichert, Kristin, Steuber, Holger, Lejeune, Pascale, Mumberg, Dominik, Haendler, Bernard
Published in International journal of cancer (01.09.2019)
Published in International journal of cancer (01.09.2019)
Get full text
Journal Article
The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer Models
Wengner, Antje M, Siemeister, Gerhard, Lücking, Ulrich, Lefranc, Julien, Wortmann, Lars, Lienau, Philip, Bader, Benjamin, Bömer, Ulf, Moosmayer, Dieter, Eberspächer, Uwe, Golfier, Sven, Schatz, Christoph A, Baumgart, Simon J, Haendler, Bernard, Lejeune, Pascale, Schlicker, Andreas, von Nussbaum, Franz, Brands, Michael, Ziegelbauer, Karl, Mumberg, Dominik
Published in Molecular cancer therapeutics (01.01.2020)
Published in Molecular cancer therapeutics (01.01.2020)
Get full text
Journal Article
Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer
Hammer, Stefanie, Hagemann, Urs B, Zitzmann-Kolbe, Sabine, Larsen, Aasmund, Ellingsen, Christine, Geraudie, Solene, Grant, Derek, Indrevoll, Baard, Smeets, Roger, von Ahsen, Oliver, Kristian, Alexander, Lejeune, Pascale, Hennekes, Hartwig, Karlsson, Jenny, Bjerke, Roger M, Ryan, Olav B, Cuthbertson, Alan S, Mumberg, Dominik
Published in Clinical cancer research (15.04.2020)
Published in Clinical cancer research (15.04.2020)
Get full text
Journal Article
Abstract 1795: Darolutamide demonstrates greater in vivo activity than enzalutamide in prostate cancer model with therapy-resistant androgen receptor mutation
Haendler, Bernard, Sugawara, Tatsuo, Baumgart, Simon J., Lejeune, Pascale
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
A planar micro thermoelectric generator with high thermal resistance
Yuan, Zheng, Ziouche, Katir, Bougrioua, Zahia, Lejeune, Pascale, Lasri, Tuami, Leclercq, Didier
Published in Sensors and actuators. A. Physical. (01.01.2015)
Published in Sensors and actuators. A. Physical. (01.01.2015)
Get full text
Journal Article
Abstract 924: The androgen receptor antagonist darolutamide shows strong antitumor efficacy in patient- and cell line-derived xenograft prostate cancer models
Lejeune, Pascale, Wengner, Antje, Baumgart, Simon J., Nevedomskaya, Ekaterina, Corey, Eva, Mumberg, Dominik, Haendler, Bernard
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Abstract A028: In vitro and in vivo efficacy of the androgen receptor antagonist darolutamide in prostate cancer models
Sugawara, Tatsuo, Baumgart, Simon J., Reichert, Kristin, Lejeune, Pascale, Haendler, Bernard
Published in Cancer research (Chicago, Ill.) (15.08.2018)
Published in Cancer research (Chicago, Ill.) (15.08.2018)
Get full text
Journal Article